Literature DB >> 19738468

Diet and asthma.

Stacy Raviv1, Lewis J Smith.   

Abstract

PURPOSE OF REVIEW: The goal of this review is to assess recent additions to the medical literature that contribute to the clinical question: 'How might diet act as a disease modifier in patients with asthma?' In vitro, animal, and epidemiologic data are presented as justification for interventional studies, which form the basis of clinical recommendations and decision-making. RECENT
FINDINGS: A number of studies suggest roles for n-3 fatty acids, soy isoflavones, vitamin D, and antioxidants as modifiers of asthma severity. However, these studies are generally complicated by small sample sizes and either negative results or findings that are of questionable clinical significance.
SUMMARY: The available literature regarding dietary manipulation as asthma therapy is largely unconvincing. Although mechanistic and epidemiologic studies provide a rationale for diet therapies, there are few interventional studies with positive, clinically relevant endpoints. Future studies must include sufficient numbers of well selected patients and measure effects on exacerbations, symptoms, lung function, and medication use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19738468     DOI: 10.1097/MCP.0b013e3283323b73

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  7 in total

1.  Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study.

Authors:  Jingjing Li; Pengcheng Xun; Daisy Zamora; Akshay Sood; Kiang Liu; Martha Daviglus; Carlos Iribarren; David Jacobs; James M Shikany; Ka He
Journal:  Am J Clin Nutr       Date:  2012-11-28       Impact factor: 7.045

Review 2.  Impact of fatty acid status on immune function of children in low-income countries.

Authors:  Andrew M Prentice; Liandré van der Merwe
Journal:  Matern Child Nutr       Date:  2011-04       Impact factor: 3.092

3.  Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.

Authors:  Lewis J Smith; Ravi Kalhan; Robert A Wise; Elizabeth A Sugar; John J Lima; Charles G Irvin; Allen J Dozor; Janet T Holbrook
Journal:  JAMA       Date:  2015-05-26       Impact factor: 56.272

4.  Soy isoflavones reduce asthma exacerbation in asthmatic patients with high PAI-1-producing genotypes.

Authors:  Seong H Cho; Ara Jo; Thomas Casale; Su J Jeong; Seung-Jae Hong; Joong K Cho; Janet T Holbrook; Rajesh Kumar; Lewis J Smith
Journal:  J Allergy Clin Immunol       Date:  2019-01-29       Impact factor: 10.793

5.  Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice.

Authors:  Gertrud U Schuster; Jennifer M Bratt; Xiaowen Jiang; Theresa L Pedersen; Dmitry Grapov; Yuriko Adkins; Darshan S Kelley; John W Newman; Nicholas J Kenyon; Charles B Stephensen
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

6.  Evaluation of the protective and ameliorative properties of Garcinia kola on histamine-induced bronchoconstriction in guinea pigs.

Authors:  Mina T Ibulubo; Gerald I Eze; Raymond I Ozolua; Doroteo Baxter-Grillo; Dickson O Uwaya
Journal:  Pharmacognosy Res       Date:  2012-10

Review 7.  Flavonoids and asthma.

Authors:  Toshio Tanaka; Ryo Takahashi
Journal:  Nutrients       Date:  2013-06-10       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.